Pharmacy - Drug Approvals News & Articles

341 Medtronic announces FDA approval of df4 high-voltage connector system for implantable cardioverter defibrillator and cardiac resynchronization therapy devices Full Text Medtronic, February 1, 2012

342 FDA approves erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma Full Text Genentech, January 31, 2012

343 View information and materials on the approval Full Text Genentech, January 31, 2012

344 Covidien revascularization device approved for interventional management of stroke trial Covidien, January 31, 2012

345 Inhaled treprostinil: a therapeutic review Full Text Drug Design, Development and Therapy, January 30, 2012

346 FDA approves bydureon-the first and only once-weekly treatment for type 2 diabetes Full Text Amylin Pharmaceuticals, January 30, 2012

347 Bristol-myers squibb delivers solid fourth quarter capping a year highlighted by new product approvals, continued execution of strategic transactions and good operating performance Full Text Bristol Myers-Squibb, January 27, 2012

348 FDA approves drugs for BPH, AF Full Text Drug Topics, January 26, 2012

349 Designation of regulatory starting materials in the manufacturing of drug substances: impact on anda review time Full Text Pharmaceutical Technology, January 26, 2012

350 Genzyme announces FDA approval of framingham manufacturing plant Full Text Genzyme, January 25, 2012

351 Genzyme announces FDA approval of framingham manufacturing plant Full Text Sanofi, January 25, 2012

352 Cell therapeutics, inc. expects that the european medicines agency's (ema) committee for medicinal products for human use (chmp) may issue an opinion on the marketing authorization application ("maa") on pixuvri in mid-february Full Text Cell Therapeutics, January 24, 2012

353 FDA Actions in Brief January 2012 (Antares, Isentress, REMS) Full Text Formulary , January 23, 2012

354 FDA advisory committee declines to recommend approval of progesterone vaginal gel 8% for the reduction of risk of preterm birth in women with short uterine cervical length Full Text Actavis, January 23, 2012

355 Chmp recommends EU approval to update novartis drug glivec label to include three year treatment for GIST patients after surgery Full Text Novartis, January 23, 2012

356 Novartis drug Signifor recommended by CHMP for EU approval to treat patients with Cushing's disease Full Text Novartis, January 23, 2012

357 Bristol-myers squibb and astrazeneca receive complete response letter from U.S. food and drug administration for dapagliflozin Full Text AstraZeneca, January 20, 2012

358 Meeting global patient demand for access to medicines prior to approval and launch Pharmaceutical Executive Magazine, January 20, 2012

359 Bristol-myers squibb and astrazeneca receive complete response letter from U.S. food and drug administration for dapagliflozin Full Text Bristol Myers-Squibb, January 20, 2012

360 U.S. food and drug administration approves new formulations of viread for use by children living with hiv Full Text Gilead, January 20, 2012

1 Phentermine and topiramate for the management of obesity: a review Drug Design, Development and Therapy, April 12, 2013    Free full text    Review Article

2 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

3 FDA approves three new drug treatments for type 2 diabetes FDA Press Announcements, January 29, 2013    Free full text

4 Tadalafil: A Phosphodiesterase-5 Inhibitor for Benign Prostatic Hyperplasia Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, April 2, 2013

5 Unapproved Drugs--The Drug Information Pharmacists Perspective Journal of Pharmacy Practice, March 29, 2013    Review Article

6 Ceftaroline - a cause for neutropenia Journal of Clinical Pharmacy and Therapeutics, April 22, 2013

7 Novartis receives EU approval for Ilaris in patients suffering acute gouty arthritis attacks who cannot gain relief from current treatments Novartis, March 4, 2013    Free full text

8 FDA approves new multiple sclerosis treatment: Tecfidera FDA Press Announcements, April 1, 2013    Free full text

9 Benefits and Risks of Daily Aspirin Use U.S. Pharmacist, February 27, 2013    Free full text

10 Actemra, a Treatment for Rheumatoid Arthritis Obtained Approval for Subcutaneous Injection Formulation Chugai Pharmaceutical Co., March 26, 2013    Free full text

11 Merck Announces Breakthrough Therapy Designation for Lambrolizumab an Investigational Antibody Therapy for Advanced Melanoma Merck, April 29, 2013    Free full text

12 Sarepta Therapeutics Announces FDA Will Consider Accelerated Approval for Eteplirsen After Further Review of Data on Dystrophin and Clinical Outcomes Sarepta Therapeutics, April 19, 2013    Free full text

13 FDA Advisory Committee Recommends Approval for Boehringer Ingelheims Olodaterol* for Maintenance Treatment of COPD Boehringer Ingelheim, January 31, 2013    Free full text

14 FDA Lists Guidance Documents Planned for 2013 BioPharm International, February 11, 2013    Free full text

15 Apixaban: Third oral anticoagulant to compete with warfarin American Pharmacists Association News, March 14, 2013    Free full text

16 Pomalidomide: Thalidomide analogue for multiple myeloma American Pharmacists Association News, April 5, 2013    Free full text

17 FDA approves abuse-deterrent labeling for reformulated OxyContin FDA Press Announcements, April 18, 2013    Free full text

18 FDA approves first Botulism Antitoxin for use in neutralizing all seven known botulinum nerve toxin serotypes FDA Press Announcements, March 25, 2013    Free full text

19 Quality-improvement analytics for intravenous infusion pumps American Journal of Health-System Pharmacy, April 11, 2013

20 Targeting kinases: a new approach to treating inflammatory rheumatic diseases Current Opinion in Pharmacology , March 22, 2013    Review Article